Enfusion Inc. (ENFN)

AI Score

Unlock

10.76

-0.04 (-0.37%)

At close: Apr 17, 2025, 3:59 PM

10.61

-1.37%

After-hours: Apr 17, 2025, 08:00 PM EDT

Enfusion Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Mar 31, 2020
Cash & Equivalents	54.48M	48.3M	34.45M	32.89M	35.6M	31.65M	27.77M	54.6M	62.55M	63.54M	56.56M	56.21M	64.36M	8.43M	14.52M	-13.94M	13.94M	-5.9M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	27.88M	n/a	11.8M
Long-Term Investments	n/a	3M	3M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	10.71M	7.07M	7.2M	7.04M	6.5M	5.83M	4.53M	4.53M	4.48M	4.15M	3.78M	3.5M	3.36M	1.63M	1.55M	-13.94M	1.4M	-5.9M
Receivables	31.99M	32.17M	33.67M	30.93M	28.07M	24.86M	25.17M	24.36M	25.86M	28.99M	28.77M	23.41M	18.22M	19M	15.47M	n/a	12.18M	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	4.08M	4.97M	5.6M	6.11M	2.6M	3.63M	5.46M	1.00	n/a	n/a	n/a	n/a	n/a
Other Current Assets	7.05M	1.39M	1.57M	1.68M	1.17M	1.46M	1.72M	2.09M	2.3M	888K	1.29M	1.33M	7.09M	n/a	n/a	n/a	n/a	n/a
Total Current Assets	93.52M	85.44M	74.17M	70.92M	69.85M	62.05M	59.63M	86.65M	96.81M	96.03M	90.25M	86.41M	89.68M	35.51M	34.12M	13.94M	28.91M	5.9M
Property-Plant & Equipment	39.02M	39.44M	35.73M	33M	32.62M	33.87M	29.89M	30.32M	22.49M	15.42M	16.09M	15.05M	13.05M	12.5M	11.54M	n/a	8.78M	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	49.74M	49.5M	45.92M	40.04M	39.12M	39.7M	34.43M	34.85M	26.98M	19.57M	19.88M	18.55M	16.41M	14.12M	13.09M	-13.94M	10.19M	-5.9M
Total Assets	143.26M	134.94M	120.09M	110.96M	108.97M	101.74M	94.05M	121.49M	123.78M	115.6M	110.13M	104.95M	106.08M	49.63M	47.2M	n/a	39.1M	n/a
Account Payables	867K	1.18M	816K	3.36M	2.21M	1.34M	868K	1.29M	1.69M	1.19M	879K	1.19M	2.53M	2.31M	1.25M	n/a	484K	n/a
Deferred Revenue	n/a	n/a	2.02M	2.24M	2.4M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.04M	848K	n/a	7.4M	n/a
Short-Term Debt	6.08M	5.93M	5.19M	-2.24M	4.26M	4.4M	n/a	5.01M	4.03M	n/a	n/a	n/a	n/a	5M	2.5M	n/a	2.5M	n/a
Other Current Liabilities	20.39M	5.64M	5.1M	n/a	8.2M	5.2M	1.69M	-136K	6.24M	1.96M	1.92M	2.58M	2.4M	1.04M	848K	n/a	709K	n/a
Total Current Liabilities	27.34M	23.57M	17.87M	17.41M	20.31M	16.37M	13.76M	13.71M	17.38M	11.99M	9.84M	7.75M	8.11M	16.28M	12.88M	n/a	10.65M	n/a
Long-Term Debt	14.24M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	92.53M	96.21M	n/a	96.06M	n/a
Other Long-Term Liabilities	2.15M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	443K	479K	497K	538K	170.45M	168.99M	n/a	165.94M	n/a
Total Long-Term Liabilities	16.39M	15.19M	12.8M	10.93M	11.18M	12.09M	8.05M	8.64M	2.96M	443K	479K	497K	538K	262.99M	265.2M	n/a	262.01M	n/a
Total Liabilities	43.72M	38.76M	30.68M	28.34M	31.49M	28.46M	21.81M	22.35M	20.34M	12.43M	10.32M	8.24M	8.64M	279.27M	278.09M	n/a	272.66M	n/a
Total Debt	20.31M	21.13M	18M	15.46M	15.44M	16.49M	12.81M	13.65M	6.99M	n/a	n/a	n/a	n/a	97.53M	98.71M	n/a	98.56M	n/a
Common Stock	129K	128K	128K	128K	127K	127K	123K	115K	114K	113K	113K	113K	113K	n/a	113K	n/a	n/a	n/a
Retained Earnings	-170.11M	-170.23M	-171.65M	-173.47M	-172.93M	-173.56M	-175.38M	-176.01M	-178.86M	-179.36M	-180.9M	-178.47M	-328K	-169.87M	-171.21M	n/a	-165.51M	n/a
Comprehensive Income	-734K	-199K	-509K	-484K	-406K	-548K	-378K	-473K	-504K	-672K	-582K	-375K	-171.21M	-306K	-289K	-233.56M	-212K	-117.88M
Shareholders Equity	73.22M	69.92M	64.3M	58.05M	53.67M	50.73M	48.13M	63.7M	65.01M	61.13M	59.14M	54.87M	55.29M	-229.63M	-230.88M	-68.04M	-233.56M	-12.81M
Total Investments	n/a	3M	3M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	27.88M	n/a	11.8M